Baird Medical Investment Holdings Limited (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in microwave ablation (MWA) technology, today announced that its PRC subsidiary, Nanjing Changcheng Medical Equipment Company Limited, has entered into a distribution agreement with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. ("China Resources Medical Devices"), a subsidiary of China Resources Pharmaceutical Group Limited (Stock Code: 03320.HK).

Under the agreement, China Resources Medical Devices will serve as the exclusive distributor for Baird’s specified MWA products in 19 key markets in the People’s Republic of China, with a focus on regions where Baird has historically had a limited direct commercial presence. On execution of the agreement, China Resources Medical Devices placed an initial order totaling approximately RMB 6 million ($900,000).

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.